Results 221 to 230 of about 45,588 (281)

Biological implications and therapeutic potential of phosphodiesterase inhibitors: A review. [PDF]

Medicine (Baltimore)
Alnazari M, Bakhsh A, Abdullah S, Al Qahtani S, Borhan W, Rajih E, Alshehri AM.   +6 more
europepmc   +1 more source

The Influence of TDP1 Inhibitor Usnic Acid Derivative OL9-116 on the Effects of Topotecan in Human Cells. [PDF]

Curr Issues Mol Biol
Kornienko TE, Chepanova AA, Kolobenko MV, Chernyshova IA, Zakharenko AL, Venzel AS, Dyrkheeva NS, Markov AV, Anarbaev RO, Naumenko KN, Luzina OA, Salakhutdinov NF, Ivanisenko VA, Lavrik OI.   +13 more
europepmc   +1 more source

Structural and biochemical insights into the inhibition of <i>Mycobacterium tuberculosis</i> cyclic dinucleotide phosphodiesterase by a sulfur-modified cyclic dinucleotide analog. [PDF]

RSC Chem Biol
Hanuman DS, Neeharika S, Murari SK, Yeboah SK, Sintim HO, Rajakumara E.   +5 more
europepmc   +1 more source

Roflumilast Enhances Liraglutide's Atrial Natriuretic Peptide-Dependent Suppression of Adrenal Aldosterone Secretion. [PDF]

Int J Mol Sci
Hosseini A, M'Sadoques AJ, Stoicovy RA, Altsman VL, Raynshteyn L, Weinstein E, Baggio Lopez T, Del Calvo G, Leiker MG, Lymperopoulos A.   +9 more
europepmc   +1 more source

Improved survival with phosphodiesterase-5 inhibitor use in men with male-predominant cancers: real-world large database study. [PDF]

Front Oncol
Uralov D, Harrington SR, Samarah H, Walia AS, Aweeda M, Mustafa MU, Kumar P, Briskin A, Jackson J, Mastrolonardo EV, Luginbuhl AJ.   +10 more
europepmc   +1 more source

Development of a clinical scoring system to predict response to low-intensity shock wave therapy in clinically diagnosed vasculogenic erectile dysfunction: a prospective, non-randomized, single-arm, interventional study. [PDF]

Sex Med
Anıl H, Yıldız A, Topuz AN, Kayra MV, Sözütok S, Altunkol A, Alma E, Topuz M, Bayazıt Y.   +8 more
europepmc   +1 more source

Exploration of the Role of Cilostazol in Brugada Syndrome: Mechanisms, Therapeutic Potential, and Implications in the Prevention of Ventricular Arrhythmias. [PDF]

Rev Cardiovasc Med
Iqbal M, Putra ICS, Karwiky G, Achmad C.
europepmc   +1 more source

Acute Contractile Effects of Glucagon-like-Peptide-1 Receptor Agonists in the Human Heart. [PDF]

Pharmaceutics
Neumann J, Kirchhefer U, Hofmann B, Gergs U.   +3 more
europepmc   +1 more source

Phosphodiesterase signaling in asthma: mechanistic insights and emerging therapeutic strategies. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Alnusayri A, Al-Kuraishy HM, Alexiou A, Papadakis M, Faheem SA, Alruwaili M, Batiha GE.   +6 more
europepmc   +1 more source

Phosphodiesterase 8 regulation of excitation-contraction coupling as a target for cardiovascular disease: is it my turn now? [PDF]

Am J Physiol Heart Circ Physiol
Xu (许莹) Y, McConnell BK.
europepmc   +1 more source